Abstract
Introduction
Combined glucocorticoids and cyclophosphamide pulse therapy showed promising results in moderate-to-severe paraquat poisonings to reduce life-threatening respiratory complications. Its benefit has been observed when given early in the course of poisoning; however, whether its delayed administration remains beneficial is unknown.
Case Report
We describe a 23-year-old male who ingested 70 mL of a commercialized concentrate formulation with 20% weight/volume paraquat in a suicide attempt. Within 24 hours from paraquat ingestion, he presented most of the indicators of poor outcome, including gastritis, early renal dysfunction, dark blue urine colorimetric dithionite test, and marked plasma paraquat concentrations (0.56 μg/mL at 13 hours, and 0.41 μg/mL at 24 hours after ingestion). The patient received early gastrointestinal decontamination and aggressive supportive treatments. However, due to a rapidly progressive severe pulmonary infection, glucocorticoids and cyclophosphamide were delayed until day 14. Interestingly, our patient survived with mild respiratory sequelae despite poor initial prognosis.
Discussion
This observation suggests the potential benefit of immunosuppressive pulse therapy, even if administered 14 days after paraquat ingestion, and highlights the role of paraquat-induced alveolitis in the development of fibrosis.
Conclusion
Combined glucocorticoids and cyclophosphamide should be considered in moderate-to-severe paraquat poisonings, even if delayed.
Keywords: paraquat, acute poisoning, respiratory failure, prognosis, pulse therapy
Full Text
The Full Text of this article is available as a PDF (92.7 KB).
Footnotes
There was no outside funding of any kind used for this study.
References
- 1.Bismuth C, Garnier R, Baud FJ, et al. Paraquat poisoning. An overview of the current status. Drug Saf. 1990;5:243–251. doi: 10.2165/00002018-199005040-00002. [DOI] [PubMed] [Google Scholar]
- 2.Lin JL, Leu ML, Liu YC, et al. A prospective clinical trial of pulse therapy with glucocorticoid and cyclophosphamide in moderate to severe paraquat-poisoned patients. Am J Respir Crit Care Med. 1999;159:357–360. doi: 10.1164/ajrccm.159.2.9803089. [DOI] [PubMed] [Google Scholar]
- 3.Chen GH, Lin JL, Huang YK. Combined methylprednisolone and dexamethasone therapy for paraquat poisoning. Crit Care Med. 2002;30:2584–2587. doi: 10.1097/00003246-200211000-00030. [DOI] [PubMed] [Google Scholar]
- 4.Lin NC, Lin JL, Lin-Tan DT, et al. Combined initial cyclophosphamide with repeated methylprednisolone pulse therapy for severe paraquat poisoning from dermal exposure. J Toxicol/Clin Toxicol. 2003;41:877–881. doi: 10.1081/clt-120025356. [DOI] [PubMed] [Google Scholar]
- 5.Lin JL, Lin-Tan DT, Chen KH, et al. Repeated pulse of methylprednisolone and cyclophosphamide with continuous dexamethasone therapy for patients with severe paraquat poisoning. Crit Care Med. 2006;34:368–373. doi: 10.1097/01.CCM.0000195013.47004.A8. [DOI] [PubMed] [Google Scholar]
- 6.Dinis-Oliveira RJ, Sarmento A, Reis P, et al. Acute paraquat poisoning: report of a survival case following intake of a potential lethal dose. Pediatr Emerg Care. 2006;22:537–540. doi: 10.1097/01.pec.0000223179.07633.8a. [DOI] [PubMed] [Google Scholar]
- 7.Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149:818–824. doi: 10.1164/ajrccm.149.3.7509706. [DOI] [PubMed] [Google Scholar]
- 8.Bismuth C, Garnier R, Dally S, et al. Prognosis and treatment of paraquat poisoning: a review of 28 cases. J Toxicol/Clin Toxicol. 1982;19:461–474. doi: 10.3109/15563658208992501. [DOI] [PubMed] [Google Scholar]
- 9.Proudfoot AT, Stewart MS, Levitt T, et al. Paraquat poisoning: significance of plasma-paraquat concentrations. Lancet. 1979;2:330–332. doi: 10.1016/S0140-6736(79)90345-3. [DOI] [PubMed] [Google Scholar]
- 10.Scherrmann JM, Houze P, Bismuth C, et al. Prognostic value of plasma and urine paraquat concentration. Hum Toxicol. 1987;6:91–93. doi: 10.1177/096032718700600116. [DOI] [PubMed] [Google Scholar]
- 11.Hart TB, Nevitt A, Whitehead A. A new statistical approach to the prognostic significance of plasma paraquat concentrations. Lancet. 1984;2:1222–1223. doi: 10.1016/S0140-6736(84)92784-3. [DOI] [PubMed] [Google Scholar]
- 12.Eisenman A, Armali Z, Raikhlin-Eisenkraft B, et al. Nitric oxide inhalation for paraquat-induced lung injury. J Toxicol/Clin Toxicol. 1998;36:575–584. doi: 10.3109/15563659809028051. [DOI] [PubMed] [Google Scholar]
- 13.Shum S, Hale TW, Habersang R. Reduction of paraquat toxicity by N-acetylcysteine. Vet Hum Toxicol. 1987;6:91–93. doi: 10.1177/096032718700600116. [DOI] [Google Scholar]
- 14.Dinis-Oliveira RJ, Duarte JA, Remiao F, et al. Single high dose dexamethasone treatment decreases the pathological score and increases the survival rate of paraquat-intoxicated rats. Toxicology. 2006;227:73–85. doi: 10.1016/j.tox.2006.07.025. [DOI] [PubMed] [Google Scholar]
- 15.Eddleston M, Wilks MF, Buckley NA. Prospects for treatment of paraquat-induced lung fibrosis with immunosuppressive drugs and the need for better prediction of outcome: a systematic review. QJM. 2003;96:809–824. doi: 10.1093/qjmed/hcg137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Bismuth C, Hall AH, Baud FJ, et al. Pulmonary dysfunction in survivors of acute paraquat poisoning. Vet Hum Toxicol. 1996;38:220–222. [PubMed] [Google Scholar]
- 17.Lin JL, Liu L, Leu ML. Recovery of respiratory function in survivors with paraquat intoxication. Arch Environ Health. 1995;50:432–439. doi: 10.1080/00039896.1995.9935979. [DOI] [PubMed] [Google Scholar]
- 18.Yamashita M, Yamashita M, Ando Y. A long-term followup of lung function in survivors of paraquat poisoning. Hum Exp Toxicol. 2000;19:99–103. doi: 10.1191/096032700678815729. [DOI] [PubMed] [Google Scholar]